Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 4.66% | $89.33M | ― | ― | ― | |
| ASML Holding NV | 4.40% | $84.24M | €482.60B | 82.23% | 76 Outperform | |
| SAFRAN SA | 3.36% | $64.45M | €140.14B | 39.51% | 67 Neutral | |
| AstraZeneca | 2.97% | $56.93M | $320.89B | 28.44% | 80 Outperform | |
| Rolls-Royce Holdings | 2.83% | $54.28M | £110.40B | 125.74% | 71 Outperform | |
| TSMC | 2.61% | $50.08M | $1.63T | 103.70% | 81 Outperform | |
| Skandinaviska Enskilda Banken AB | 2.31% | $44.24M | kr389.56B | 12.78% | 71 Outperform | |
| UniCredit SpA | 2.17% | $41.55M | €113.57B | 67.97% | 75 Outperform | |
| RWE AG | 2.00% | $38.34M | €39.19B | 72.21% | 69 Neutral | |
| ― | 1.84% | $35.17M | ― | ― | ― |